Evaluation of blood-based screening tests for colorectal neoplasia; from biomarker candidates to accurate and acceptable tests

点击翻译按钮获取中文摘要

Current bowel cancer screening tests require people to collect a stool sample. While able to be done at home, this creates certain inconveniences and has other barriers to its use including being distasteful to some. Also, even though stool tests are useful they are not as accurate as we would like. We have discovered a molecule in the blood of patients with bowel cancer that could, if configured as a screening test, serve to be of even greater accuracy and also be more acceptable to people.